We use cookies and other tools to enhance your experience on our website and to analyze our web traffic.
For more information about these cookies and the data collected, please refer to our Privacy Policy.

Search

dm_control under Clinical Characteristics in HCHS variables
This variable indicates controlled diabetes. Defined only for diabetics.
dm_aware under Clinical Characteristics in HCHS variables
This variable describes the awareness of diabetes. Defined only for self-reported diabetics.
dm_aware_sueno under Clinical Characteristics in HCHS variables
This variable describes the awareness of diabetes. Defined only for self-reported diabetics.
Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-be
... S, Grobman WA, Haas DM, Wing DA, Mercer BM, ...
Sleep Heart Health Study
... FJ, O'Connor GT, Rapoport DM, Redline S, Robbins J, ...
incl04_diab under Administrative/Eligibility in HEARTBEAT variables
inclusion04 under Administrative/Eligibility in HEARTBEAT variables
diabetes under Medications in HEARTBEAT variables
diabetes_n under Medications in HEARTBEAT variables
dxdiab under Questionnaires/Sleep and Health in HEARTBEAT variables
dxdiabage under Questionnaires/Sleep and Health in HEARTBEAT variables
dxdiabinsulin under Questionnaires/Sleep and Health in HEARTBEAT variables
dxdiabmed under Questionnaires/Sleep and Health in HEARTBEAT variables
dxdiabmedno under Questionnaires/Sleep and Health in HEARTBEAT variables
dxdiabmedtype under Questionnaires/Sleep and Health in HEARTBEAT variables
dxdiab under Medical History in HOMEPAP variables
insuln1 under Medical History/Medications/SHHS1 in SHHS variables
Participant taking INSULINS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ohga1 under Medical History/Medications/SHHS1 in SHHS variables
Participant taking ORAL HYPOGLYCEMIC AGENTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
agdi2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ALPHA-GLUCOSIDASE INHIBITORS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
bgnd2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking BIGUANIDES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
insuln2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking INSULINS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
kblkr2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
ohga2 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking ORAL HYPOGLYCEMIC AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
slf12 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking FIRST GENERATION SULFONYLUREAS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.
slf22 under Medical History/Medications/SHHS2 in SHHS variables
Participant taking SECOND GENERATION SULFONYLUREAS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.